Long-term treatment with natalizumab in paediatric multiple sclerosis (MS)

被引：0
|
作者：
Talab, R. [1 ]
Talabova, M. [2 ]
机构：
[1] Charles Univ Prague, Dept Neurol, Fac Med Plzen, Prague, Czech Republic
[2] Univ Hosp Hradec Kralove, MS Ctr, Hradec Kralove, Czech Republic
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-70
引用
收藏
页码：471 / 472
页数：2
相关论文
共 50 条
  • [21] Corticosteroids for the long-term treatment in multiple sclerosis
    Ciccone, A.
    Beretta, S.
    Brusaferri, F.
    Galea, I
    Protti, A.
    Spreafico, C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [22] LONG-TERM TREATMENT OF MULTIPLE SCLEROSIS WITH CORTICOIDS
    FOG, T
    ACTA NEUROLOGICA SCANDINAVICA, 1965, S 41 : 473 - &
  • [23] Long-term safety of natalizumab treatment in multiple sclerosis (MS) in clinical practice: results from the tysabri global observational program in safety (TYGRIS)
    Foley, J.
    Carrillo-Infante, C.
    Wenten, M.
    Lavallee, N.
    Smith, J.
    Evans, K.
    Haddock, B.
    Steiner, D.
    Ho, P. -R.
    Lee, L.
    Vermersch, P.
    Hutchinson, M.
    Pozzilli, C.
    Bloomgren, G.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 646 - 647
  • [24] Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple Sclerosis
    Raffel, Joel
    Gafson, Arie R.
    Dandaleh, Samer
    Malik, Omar
    Jones, Brynmor
    Nicholas, Richard
    PLOS ONE, 2017, 12 (01):
  • [25] Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study
    O'Connor, Paul
    Goodman, Andrew
    Kappos, Ludwig
    Lublin, Fred
    Polman, Chris
    Rudick, Richard A.
    Hauswirth, Kathy
    Cristiano, Lynda M.
    Forrestal, Fiona
    Duda, Petra
    NEUROLOGY, 2014, 83 (01) : 78 - 86
  • [26] Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study
    Csepany Tuende
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2014, 67 (7-8): : 277 - 279
  • [27] Case History Long-Term Treatment of relapsing-remitting MS with Natalizumab
    Sievers, Carsten
    NERVENHEILKUNDE, 2013, 32 (10) : 786 - 786
  • [28] Long-term cognitive consequences of paediatric-onset multiple sclerosis
    McKay, K. A.
    Hillert, J.
    Olsson, T.
    Manouchehrinia, A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 542 - 542
  • [29] Long-term disability progression of paediatric-onset multiple sclerosis
    McKay, K. A.
    Hillert, J.
    Manouchehrinia, A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 544 - 544
  • [30] Confirmed Progression independent of Relapse Activity in Multiple Sclerosis Patients under long-term Natalizumab Treatment.
    Graf, Jonas
    Leussink, Verena
    Soncin, Giulia
    Lepka, Klaudia
    Meinl, Ingrid
    Kumpfel, Tania
    Hartung, Hans-Peter
    Havla, Joachim
    Aktas, Orhan
    Albrecht, Philipp
    NEUROLOGY, 2020, 94 (15)
12345